LATAM Cargo becomes the first airline in the Americas to obtain International Air Transport Association’s CEIV Pharma certification affirming the carrier’s processes comply with IATA’s standards for the transport of pharmaceutical products to ensure the integrity of the product throughout the supply chain.
The certification follows closely that of Miami International Airport (MIA), LATAM Cargo’s strategic US hub, which obtained its CEIV certification earlier this year. “As the first airport in the western hemisphere designated by IATA as a pharma hub, and now as home to the first airline in America certified by IATA for pharma transport excellence, we are proud to collaborate with LATAM Cargo and our other hub partners to be the unrivaled pharma gateway of the Americas”, said Miami-Dade Aviation director Emilio T. González.
“Pharma trade to and from MIA continues to be a huge growth area for us, most recently surging by 48 per cent in value year over year to US$4.4 billion in 2016,” he added.
LATAM Cargo underwent a final audit in January 2017 to verify that the company and its processes – such as quality management, personnel training, supplier management, internal auditing and transport, among others – comply with the standards for the transportation of pharmaceutical products.
“This certification demonstrates the quality and consistency of our PHARMA product,” said Andres Bianchi, CEO of LATAM Cargo. “As the first airline in the Americas to obtain this certification, we reaffirm our aim of becoming the preferred choice for cargo transport to, from and inside Latin America. It also reflects our commitment to deliver excellent service to our customers.”
Since this global certification began in Brussels in 2014, it has been gaining recognition from airlines, airports, freight forwarders and shippers. Its overall goal is to raise industry know-how and achieve global standardisation, thus contributing to the improvement of pharmaceutical handling. Prior to certification, in March 2016 LATAM Cargo carried out an internal assessment of its capacities and processes for handling of these products.
“We are very pleased that LATAM Cargo has achieved CEIV Pharma certification,” said Peter Cerda, IATA’s regional VP for the Americas. “This globally recognised standard is a guarantee of safety, security, compliance and efficiency for the high value shipment of pharmaceuticals.
“IATA is striving to support the modernisation of the air cargo industry and CEIV Pharma is an example of how by partnering for mutual benefit we can generate value for stakeholders across the air cargo value chain and most importantly, our customers”, said Cerda.
Cristina Oñate, LATAM Cargo Marketing and Product Development VP, added that “the CEIV certification process has been beneficial for LATAM Cargo. It has provided access to new assessment and control tools, which we have helped to improve our Pharma product”.
With this certification, which is valid for three years, LATAM Cargo has positioned itself as a leading airline in the transport of Pharma between Latin America and North America as well as Europe. It has also demonstrated its commitment to the pharmaceutical industry and its customers, by ensuring it meets the rigorous standards to transport these products.